Linked Data API

Show Search Form

Search Results

1008479
star this property registered interest false more like this
star this property date less than 2018-11-16more like thismore than 2018-11-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether he plans to make flash glucose monitoring technology available to all patients with diabetes across clinical commissioning groups. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 192108 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-11-26more like thismore than 2018-11-26
star this property answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine more like this
star this property grouped question UIN
192109 more like this
192110 more like this
star this property question first answered
less than 2018-11-26T17:43:55.08Zmore like thismore than 2018-11-26T17:43:55.08Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1008480
star this property registered interest false more like this
star this property date less than 2018-11-16more like thismore than 2018-11-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential savings to the NHS of making flash glucose monitoring technology available to all patients with diabetes across NHS clinical commissioning groups. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 192109 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-11-26more like thismore than 2018-11-26
star this property answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine more like this
star this property grouped question UIN
192108 more like this
192110 more like this
star this property question first answered
less than 2018-11-26T17:43:55.127Zmore like thismore than 2018-11-26T17:43:55.127Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1008481
star this property registered interest false more like this
star this property date less than 2018-11-16more like thismore than 2018-11-16
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what representations he has received from (a) the public and (b) charities on the benefits of making flash glucose monitoring technology available to all patients with diabetes. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 192110 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-11-26more like thismore than 2018-11-26
star this property answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine more like this
star this property grouped question UIN
192108 more like this
192109 more like this
star this property question first answered
less than 2018-11-26T17:43:55.157Zmore like thismore than 2018-11-26T17:43:55.157Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1083525
star this property registered interest false more like this
star this property date less than 2019-03-07more like thismore than 2019-03-07
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent steps he has taken to widen access to blood glucose monitoring technology for diabetes patients. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 229721 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-03-15more like thismore than 2019-03-15
star this property answer text <p>Glucose monitoring technology, such as continuous glucose monitoring or blood glucose test strips, will continue to be available to those meeting the relevant clinical criteria.</p><p> </p><p>In November 2018, NHS England announced that it will ensure that flash glucose monitoring is available on prescription for all patients who qualify for it in line with current recommendations. From April 2019, all qualifying patients will be able to receive it from their local general practitioner or diabetes team.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-03-15T12:24:05.153Zmore like thismore than 2019-03-15T12:24:05.153Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1129746
star this property registered interest false more like this
star this property date less than 2019-06-04more like thismore than 2019-06-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans he has to increase access to the Freestyle Libre monitoring device for diabetes patients. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 259980 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-06-12more like thismore than 2019-06-12
star this property answer text <p>Glucose monitoring technology, such as flash glucose monitors like Freestyle Libre will continue to be available to those meeting the relevant clinical criteria.</p><p>The NHS Long Term Plan announced that the National Health Service will ensure that, in line with clinical guidelines, eligible patients with type 1 diabetes benefit from life changing flash glucose monitors from April 2019, ending the variation patients in some parts of the country are facing.</p><p>NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf</a></p><p> </p><p>Clinical commissioning groups (CCGS) will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p>
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 259981 more like this
star this property question first answered
less than 2019-06-12T16:02:36.377Zmore like thismore than 2019-06-12T16:02:36.377Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1129747
star this property registered interest false more like this
star this property date less than 2019-06-04more like thismore than 2019-06-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure equitable access to the Freestyle Libre monitoring device for diabetes patients on the NHS. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 259981 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-06-12more like thismore than 2019-06-12
star this property answer text <p>Glucose monitoring technology, such as flash glucose monitors like Freestyle Libre will continue to be available to those meeting the relevant clinical criteria.</p><p>The NHS Long Term Plan announced that the National Health Service will ensure that, in line with clinical guidelines, eligible patients with type 1 diabetes benefit from life changing flash glucose monitors from April 2019, ending the variation patients in some parts of the country are facing.</p><p>NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding-v1.1.pdf</a></p><p> </p><p>Clinical commissioning groups (CCGS) will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p>
star this property answering member constituency South Ribble more like this
unstar this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 259980 more like this
star this property question first answered
less than 2019-06-12T16:02:36.423Zmore like thismore than 2019-06-12T16:02:36.423Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1166923
star this property registered interest false more like this
star this property date less than 2019-10-28more like thismore than 2019-10-28
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans his Department has to widen the NHS England criteria under which diabetes patients can receive the Freestyle Libre glucose monitoring device on prescription to include type 2 diabetics. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 6361 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-11-05more like thismore than 2019-11-05
star this property answer text <p>Clinical commissioning groups are responsible for commissioning diabetes services for their local populations. They are also expected to take National Institute for Health and Care Excellence (NICE) guidelines into consideration when making their decisions. NICE currently recommends not routinely offering self-monitoring of blood glucose levels for adults with type 2 diabetes unless the person:</p><p> </p><p>- is on insulin;</p><p>- or there is evidence of hypoglycaemic episodes;</p><p>- or the person is on medication that may increase their risk of hypoglycaemia while driving or operating machinery;</p><p>- or the person is pregnant or is planning to become pregnant.</p><p> </p><p>The evidence base for the benefits and cost-effectiveness of flash glucose monitoring for people with type 2 diabetes is still developing, and NICE will continue to monitor the evidence and relevant research.</p><p><strong> </strong></p><p><strong> </strong></p> more like this
star this property answering member constituency Bury St Edmunds more like this
unstar this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-11-05T10:24:50.797Zmore like thismore than 2019-11-05T10:24:50.797Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
1251392
star this property registered interest false more like this
star this property date less than 2020-11-12more like thismore than 2020-11-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will instruct NHS England to amend the guidelines they issue to clinical commissioning groups to extend the criteria for the prescription of the freestyle libre glucose monitoring device to people diagnosed with Type 2 diabetes. more like this
star this property tabling member constituency York Outer more like this
unstar this property tabling member printed
Julian Sturdy more like this
star this property uin 114850 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2020-11-24more like thismore than 2020-11-24
star this property answer text <p>The criteria for being prescribed the freestyle libre glucose monitoring device were extended on 11 November 2020 to include both people with Type 1 diabetes and people who have insulin treated Type 2 diabetes who are living with a learning disability and who are recorded on their general practitioner’s learning disability register.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
unstar this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2020-11-24T16:04:10.367Zmore like thismore than 2020-11-24T16:04:10.367Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
4079
unstar this property label Biography information for Julian Sturdy more like this
964009
star this property registered interest false more like this
star this property date less than 2018-09-03more like thismore than 2018-09-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of clinical commissioning groups' commissioning of FreeStyle Libre glucose monitoring technology on patients' access to that technology throughout England. more like this
star this property tabling member constituency West Lancashire more like this
unstar this property tabling member printed
Rosie Cooper more like this
star this property uin 169910 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-09-06more like thismore than 2018-09-06
star this property answer text <p>New figures from NHS England indicate that the majority, around 140 out of 195 clinical commissioning groups (CCGs) have now approved FreeStyle Libre or uptake. Earlier this year NHS England wrote to CCGs reminding them of their responsibilities and of the guidance that exists when it comes to flash glucose monitoring, and other treatments for people with type 1 diabetes.</p><p> </p><p>NHS England continues to work with CCGs to encourage them to adopt best practice.</p> more like this
star this property answering member constituency Winchester more like this
unstar this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-09-06T10:33:05.157Zmore like thismore than 2018-09-06T10:33:05.157Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
1538
unstar this property label Biography information for Rosie Cooper more like this
712468
star this property registered interest false more like this
star this property date less than 2017-03-20more like thismore than 2017-03-20
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Diabetes: Medical Equipment remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will make it his policy to make continuous glucose monitors available on the NHS. more like this
star this property tabling member constituency Wellingborough more like this
unstar this property tabling member printed
Mr Peter Bone more like this
star this property uin 68467 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-03-23more like thismore than 2017-03-23
star this property answer text <p>Clinical commissioning groups (CCGs) are primarily responsible for commissioning diabetes services to meet the requirements of their populations. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, and are based on the available evidence, taking into account national guidelines. This should include consideration of access to continuous glucose monitoring for people with type 1 diabetes who might benefit from it.</p> more like this
star this property answering member constituency Oxford West and Abingdon more like this
unstar this property answering member printed Nicola Blackwood more like this
star this property question first answered
less than 2017-03-23T09:48:15.56Zmore like thismore than 2017-03-23T09:48:15.56Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1581
unstar this property label Biography information for Mr Peter Bone more like this